Matinas BioPharma Holdings Inc (MTNB)
0.53
+0.01
(+1.90%)
USD |
NYAM |
Dec 24, 16:00
Matinas BioPharma Holdings Cash from Investing (Quarterly): 9.646M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Equillium Inc | 12.00M |
| Tenon Medical Inc | -0.104M |
| Alphatec Holdings Inc | -19.88M |
| Merck & Co Inc | -3.845B |
| Madrigal Pharmaceuticals Inc | -202.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.50M |
| Cash from Financing (Quarterly) | -0.067M |
| Free Cash Flow | -16.95M |
| Free Cash Flow Per Share (Quarterly) | -0.6947 |
| Free Cash Flow Yield | -683.6% |